The Abbott breakup has been very good for both companies with Abbvie actually doing better. The sleeper that I have always had a high opinion of is Lilly and they have doubled the outstanding results of Abbvie or Abbott.
Sadly I had a large position that I whittled down in the early 2006-8 era.